Mumbai has emerged as a significant hub for pharmaceutical synthesis, and particularly , it's home to several leading firms specializing in the intricate development of Omeprazole Sodium refined API (CAS 95510-70-6). These prominent operations provide premium substances crucial for managing acid-related ailments globally, cementing Mumbai’s place